Call Options

29 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.57 - $2.57 $136,210 - $136,210
53,000 Added 68.92%
129,900 $333,000
Q2 2024

Aug 15, 2024

SELL
$2.34 - $4.73 $266,292 - $538,274
-113,800 Reduced 59.67%
76,900 $197,000
Q1 2024

May 07, 2024

SELL
$4.65 - $9.31 $734,700 - $1.47 Million
-158,000 Reduced 45.31%
190,700 $938,000
Q4 2023

Feb 14, 2024

BUY
$5.81 - $11.2 $1.49 Million - $2.86 Million
255,800 Added 275.35%
348,700 $3.07 Million
Q3 2023

Nov 14, 2023

BUY
$11.47 - $25.07 $139,934 - $305,854
12,200 Added 15.12%
92,900 $1.07 Million
Q2 2023

Aug 11, 2023

SELL
$24.7 - $37.61 $4.45 Million - $6.78 Million
-180,200 Reduced 69.07%
80,700 $2.04 Million
Q1 2023

May 16, 2023

SELL
$18.36 - $35.27 $6.88 Million - $13.2 Million
-374,700 Reduced 58.95%
260,900 $8.4 Million
Q4 2022

Feb 14, 2023

BUY
$18.32 - $30.66 $6.47 Million - $10.8 Million
353,200 Added 125.07%
635,600 $11.7 Million
Q3 2022

Nov 14, 2022

BUY
$14.33 - $28.47 $2.81 Million - $5.59 Million
196,200 Added 227.61%
282,400 $7.63 Million
Q2 2022

Aug 15, 2022

SELL
$11.52 - $20.4 $778,752 - $1.38 Million
-67,600 Reduced 43.95%
86,200 $1.19 Million
Q1 2022

May 16, 2022

BUY
$12.36 - $20.31 $988,800 - $1.62 Million
80,000 Added 108.4%
153,800 $3 Million
Q4 2021

Feb 14, 2022

BUY
$12.46 - $27.87 $180,670 - $404,115
14,500 Added 24.45%
73,800 $1.2 Million
Q3 2021

Nov 15, 2021

BUY
$25.78 - $33.21 $95,386 - $122,877
3,700 Added 6.65%
59,300 $1.65 Million
Q2 2021

Aug 11, 2021

SELL
$26.8 - $31.84 $2.84 Million - $3.38 Million
-106,000 Reduced 65.59%
55,600 $1.65 Million
Q1 2021

May 17, 2021

BUY
$24.03 - $29.97 $2.39 Million - $2.98 Million
99,400 Added 159.81%
161,600 $4.52 Million
Q4 2020

Feb 16, 2021

SELL
$23.41 - $28.34 $2.15 Million - $2.6 Million
-91,700 Reduced 59.58%
62,200 $1.76 Million
Q3 2020

Nov 16, 2020

BUY
$23.23 - $34.3 $731,745 - $1.08 Million
31,500 Added 25.74%
153,900 $3.87 Million
Q2 2020

Aug 14, 2020

BUY
$12.6 - $26.55 $1.32 Million - $2.78 Million
104,700 Added 591.53%
122,400 $2.99 Million
Q1 2020

May 15, 2020

SELL
$12.46 - $27.81 $269,136 - $600,696
-21,600 Reduced 54.96%
17,700 $262,000
Q4 2019

Feb 14, 2020

BUY
$11.66 - $20.15 $300,828 - $519,869
25,800 Added 191.11%
39,300 $638,000
Q3 2019

Nov 14, 2019

SELL
$10.22 - $14.5 $32,704 - $46,400
-3,200 Reduced 19.16%
13,500 $176,000
Q2 2019

Aug 14, 2019

SELL
$10.67 - $15.49 $69,355 - $100,685
-6,500 Reduced 28.02%
16,700 $217,000
Q1 2019

May 15, 2019

BUY
$15.4 - $20.39 $120,120 - $159,042
7,800 Added 50.65%
23,200 $366,000
Q4 2018

Feb 14, 2019

SELL
$18.06 - $24.96 $95,718 - $132,288
-5,300 Reduced 25.6%
15,400 $310,000
Q3 2018

Nov 14, 2018

SELL
$23.55 - $30.1 $287,310 - $367,220
-12,200 Reduced 37.08%
20,700 $514,000
Q2 2018

Aug 14, 2018

SELL
$27.45 - $33.35 $1.12 Million - $1.36 Million
-40,900 Reduced 55.42%
32,900 $903,000
Q1 2018

May 15, 2018

BUY
$29.15 - $37.4 $953,205 - $1.22 Million
32,700 Added 79.56%
73,800 $2.27 Million
Q4 2017

Feb 14, 2018

BUY
$24.55 - $36.3 $606,385 - $896,609
24,700 Added 150.61%
41,100 $1.47 Million
Q3 2017

Nov 14, 2017

BUY
$22.55 - $28.1 $369,820 - $460,840
16,400
16,400 $452,000

Others Institutions Holding RVNC

About Revance Therapeutics, Inc.


  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.